Mahadevia Ankit
Related Filers (1)
Ownership (20)
4
Monday, 2/5/2024
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2023
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/30/2023
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/6/2023
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/3/2023
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/3/2022
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/29/2021
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/30/2021
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/3/2021
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/5/2020
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/27/2020
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/15/2020
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/10/2020
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/9/2020
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/29/2020
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/3/2020
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/2/2019
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/6/2018
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/15/2017
Spero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/1/2017
Spero Therapeutics, Inc.: Initial statement of beneficial ownership of securities